Company GI Innovation, Inc.

Equities

A358570

KR7358570000

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 03:30:00 22/05/2024 am IST			5-day change	1st Jan Change
13,010 ^KRW	-4.48%		+1.09%	+7.97%

2023	GI Innovation, Inc.(KOSDAQ:A358570) added to S&P Global BMI Index	CI
2023	GI Innovation, Inc. has completed an IPO in the amount of KRW 26 billion.	CI

GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.

KRW in Million	2022	Weight	2023	Weight	Delta
New Drug Development 100.0 %	3,500	100.0 %	5,319	100.0 %	+51.97%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	3,500	100.0 %	5,319	100.0 %	+51.97%

Managers	Title	Age	Since
Jun-Ho Hong CEO	Chief Executive Officer	52	-
Byeong-Geon Lee CEO	Chief Executive Officer	67	04/22/04
Jin-Man Kim DFI	Director of Finance/CFO	42	01/17/01
Myung-Ho Jang PSD	President	56	01/17/01
Su-Yeon Nam PSD	President	58	01/18/01
Young-Kyu Cho CTO	Chief Tech/Sci/R&D Officer	55	01/19/01
Eun-Hee Rho IRC	Investor Relations Contact	43	01/20/01
Eun-Sung Kim HRO	Human Resources Officer	44	01/21/01

Members of the board	Title	Age	Since
Byeong-Geon Lee CEO	Chief Executive Officer	67	04/22/04
Su-Yeon Nam PSD	President	58	01/18/01
Geun-Yong An BRD	Director/Board Member	49	01/22/01
Jun-Ho Hong CEO	Chief Executive Officer	52	-
Kyu-Chang Yoo BRD	Director/Board Member	64	01/22/01
Myung-Ho Jang PSD	President	56	01/17/01
Byung-Chul Kim BRD	Director/Board Member	44	01/20/01
Hyun-Chul Kim BRD	Director/Board Member	62	01/22/01
Yang-Ji Ryu BRD	Director/Board Member	56	01/22/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	44,134,599	39,179,587 ( 88.77 %)	3,000 ( 0.006797 %)	88.77 %

Name	Equities	%	Valuation
Myung-Ho Jang 6.921 %	3,054,806	6.921 %	29 M ₩
Dok-soo Jang 6.360 %	2,807,494	6.360 %	27 M ₩
Aju IB Investment Co., Ltd. (Private Equity) 5.330 %	2,352,484	5.330 %	22 M ₩
NH Investment & Securities Co., Ltd. /Private Equity/ 4.381 %	1,933,700	4.381 %	18 M ₩
YUHAN CORPORATION 3.548 %	1,566,060	3.548 %	15 M ₩
Jae-hyun Kwon 3.398 %	1,500,082	3.398 %	14 M ₩
Su-Yeon Nam 2.798 %	1,235,122	2.798 %	12 M ₩
IMARKETKOREA INC. 2.746 %	1,212,120	2.746 %	12 M ₩
Kclavis Investment Co. Ltd. 2.476 %	1,092,808	2.476 %	10 M ₩
Hye-sung Lim 2.133 %	941,558	2.133 %	9 M ₩

Name	Equities	%	Valuation
GI INNOVATION, INC. 0.01%	6,000	0.01%	57,044 $

GI Innovation, Inc.

Unit1116, Tera Tower A 167 Songpa-daero

05855, Seoul

http://www.gi-innovation.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
GI INNOVATION, INC.	+7.97%	42Cr
MODERNA, INC.	+64.23%	6.26TCr
IQVIA HOLDINGS INC.	-2.31%	4.12TCr
LONZA GROUP AG	+44.36%	4.03TCr
CELLTRION, INC.	-8.29%	2.79TCr
ICON PUBLIC LIMITED COMPANY	+11.97%	2.62TCr
ALNYLAM PHARMACEUTICALS, INC.	-21.16%	1.91TCr
BIO-TECHNE CORPORATION	+7.54%	1.31TCr
MEDPACE HOLDINGS, INC.	+27.17%	1.21TCr
UNITED THERAPEUTICS CORPORATION	+25.72%	1.23TCr

Other Biotechnology & Medical Research